Home › Hereditary Sensory and Autonomic Neuropathies › Ohio
Hereditary Sensory and Autonomic Neuropathies clinical trials in Ohio
6 studies for Hereditary Sensory and Autonomic Neuropathies are looking for participants at sites in Ohio.
Cities in Ohio
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Ohio State University, Columbus
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Oncology Hematology Care Primary, Cincinnati
- Taylor Cancer Research Center, Maumee
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT04657068First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- UH Cleveland Medical Center, Cleveland
- Stefanie Spielman Comprehensive Breast Center, Columbus
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
- Oncology Hematology Care Inc, Cincinnati
RecruitingObservational study
Ages 1 to 100 · All sexes · Updated Apr 1, 2026 · NCT05868629Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
- University of Cincinnati Medical Center, Cincinnati
RecruitingPhase 2
Ages 18 and older · Women · Updated Dec 24, 2025 · NCT06463028The Cancer of the Pancreas Screening-5 CAPS5)Study
- Case Comprehensive Cancer Center, Case Western Medical Reserve, Cleveland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 9, 2025 · NCT02000089From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.